RENAL REPLACEMENT THERAPY IN THE UNITED-STATES - DATA FROM THE UNITED-STATES RENAL DATA SYSTEM

Citation
Ly. Agodoa et Pw. Eggers, RENAL REPLACEMENT THERAPY IN THE UNITED-STATES - DATA FROM THE UNITED-STATES RENAL DATA SYSTEM, American journal of kidney diseases, 25(1), 1995, pp. 119-133
Citations number
12
Categorie Soggetti
Urology & Nephrology
ISSN journal
02726386
Volume
25
Issue
1
Year of publication
1995
Pages
119 - 133
Database
ISI
SICI code
0272-6386(1995)25:1<119:RRTITU>2.0.ZU;2-F
Abstract
This report is a summary of the discussion on the United States Renal Data System and its data contents, as presented at the Symposium on Wo rld Renal Registries on December 10, 1993, The United States Renal Dat a System is a national database that collects and analyzes information on the incidence, prevalence, morbidity, and mortality, as well as th e modalities of therapy of patients with end-stage renal disease (ESRD ) in the United States. The database is funded by the National Institu te of Diabetes and Digestive and Kidney Diseases of the National Insti tutes of Health, Data on the patients are provided by the Health Care Financing Administration Medicare Program, The coordinating center for the database, operated through a contract mechanism, was formerly at the Urban Institute in Washington, DC, but is currently located at the University of Michigan, Ann Arbor, MI. The data system contains infor mation on over 462,000 patients with more than 4 million dialysis reco rds, 2.3 million inpatient records, 94,000 transplant reports, and mor e than 290,000 follow-up reports, The incidence rate of ESRD is approx imately 180 per million population, However, the rate is higher in Afr ican-Americans (430) and Native Americans (281) than in whites (153) a nd Asian/Pacific Islanders (133). The gross mortality rate of the enti re ESRD population is approximately 168 deaths per 1,000 patient-years at risk. The death rate is higher in diabetic than in nondiabetic ESR D patients. It is also higher in ESRD patients older than 65 years (35 7) than in patients in the 45- to 64-year-old age group (158) or those in the 20- to 44-year-old age group (62). (C) 1995 by the National Ki dney Foundation, Inc.